Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 5
Submit an article Journal homepage
489
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Development and validation of the AML-QOL: a quality of life instrument for patients with acute myeloid leukemia

Sarah A. BuckleyDivisions of Clinical Research, University of Washington, Seattle, WA, USA; ;Fred Hutchinson Cancer Research Center and Division of Medical Oncology, University of Washington, Seattle, WA, USA; Correspondence[email protected]
View further author information
,
Anna B. HalpernDivisions of Clinical Research, University of Washington, Seattle, WA, USA; ;Divisions of Hematology, University of Washington, Seattle, WA, USA; View further author information
,
Megan OthusPublic Health Sciences, University of Washington, Seattle, WA, USAView further author information
,
Diana Jimenez-SahagunDivisions of Clinical Research, University of Washington, Seattle, WA, USA; View further author information
,
Roland B. WalterDivisions of Clinical Research, University of Washington, Seattle, WA, USA; ;Fred Hutchinson Cancer Research Center and Division of Medical Oncology, University of Washington, Seattle, WA, USA; View further author information
&
Stephanie J. LeeDivisions of Clinical Research, University of Washington, Seattle, WA, USA; ;Fred Hutchinson Cancer Research Center and Division of Medical Oncology, University of Washington, Seattle, WA, USA; View further author information
Pages 1158-1167 | Received 04 Nov 2019, Accepted 15 Dec 2019, Published online: 07 Jan 2020

References

  • Bertoli STS, Huynh A, Borel C, et al. Improved outcome for AML patients over the years 2000-2014. Blood Cancer J. 2017;7(12):635.
  • Estey EH. Acute myeloid leukemia: 2019 update on risk-stratification and management. Am J Hematol. 2018;93(10):1267–1291.
  • Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–447.
  • Efficace F, Gaidano G, Sprangers M, et al. Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes. Annal Oncol. 2014;25(2):447–454.
  • Yogaparan T, Panju A, Minden M, et al. Information needs of adult patients 50 or older with newly diagnosed acute myeloid leukemia. Leuk Res. 2009;33(9):1288–1290.
  • Novik A SS, Ionova T, ed. European Hematology Association Scientific Working Group Quality of Life and Symptoms. Genoa, Italy: Forum Service Editore; 2012.
  • Williams LAA, Cortes JE, Garcia Gonzalez G, et al. Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS). Blood. 2014;124(21):2652–2652.
  • Cannella L, Caocci G, Jacobs M, et al. Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned? Critic Rev Oncol Hematol. 2015;96(3):542–554.
  • Buckley SA, Kirtane K, Walter RB, et al. Patient-reported outcomes in acute myeloid leukemia: Where are we now? Blood Rev. 2018;32(1):81–87.
  • Buckley SA, Jimenez-Sahagun D, Othus M, et al. Quality of life from the perspective of the patient with acute myeloid leukemia. Cancer. 2018;124(1):145–152.
  • Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. JCO. 1998;16(1):139–144.
  • Lydick E, Epstein RS. Interpretation of quality of life changes. Qual Life Res. 1993;2(3):221–226.
  • Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994;47(1):81–87.
  • Sloan J. Asking the obvious questions regarding patient burden. JCO. 2002;20(1):4–6.
  • Cella D, Jensen SE, Webster K, et al. Measuring health-related quality of life in leukemia: the Functional Assessment of Cancer Therapy–Leukemia (FACT-Leu) questionnaire. Value Health. 2012;15(8):1051–1058.
  • Moller T, Adamsen L, Appel C, et al. Health related quality of life and impact of infectious comorbidity in outpatient management of patients with acute leukemia. Leuk Lymphoma. 2012;53:1896–1904.
  • Alibhai SM, Breunis H, Timilshina N, et al. Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age. J Geriatric Oncol. 2015;6(4):262–271.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.